Patents by Inventor Yaling Wang

Yaling Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091082
    Abstract: An ambulance-type mobile catheter room for cardiovascular interventional surgery enables interventional diagnosis and treatment devices for acute and severe cardiovascular diseases to be deployed quickly, is flexible and high in adaptability, and provides hardware devices for cardiovascular diagnosis and treatment interventional surgeons to timely diagnose and treat patients. The ambulance-type mobile catheter room for cardiovascular interventional surgery includes an ambulance. The ambulance is internally provided with an antibacterial internal environment, a robotic angiography machine system, a wireless medical Internet of Things system, a self-generating system and an auxiliary system.
    Type: Application
    Filed: March 31, 2021
    Publication date: March 21, 2024
    Applicant: GENERAL HOSPITAL OF PLA NORTHERN THEATER COMMAND
    Inventors: Yaling HAN, Jingyang SUN, Ming LIANG, Xiaozeng WANG, Yang LI, Dan LIU, Fei LI
  • Patent number: 11569303
    Abstract: A pixel arrangement structure of display panel and a display apparatus, which are used to solve the technical problem of low pixel aperture ratio of an organic light emitting diode display panel. Herein, a pixel arrangement structure of display panel includes: a plurality of sub-pixels including a first sub-pixel, a second sub-pixel, and a third sub-pixel; where the first sub-pixel, the second sub-pixel, and the third sub-pixel have a polygonal structure with different numbers of sides, and distances between any adjacent two of the plurality of sub-pixels are equal.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: January 31, 2023
    Assignee: YUNGU (GU'AN) TECHNOLOGY CO., LTD.
    Inventors: Zhihui Xiao, Junjie Huang, Ping Song, Weijian Shan, Yaling Wang, Zhiye Yang
  • Publication number: 20220330809
    Abstract: A holder for intervertebral foramen endoscope fusion includes an inner rod, an anti-torsion sleeve and an outer sleeve which are sleeved from inside to outside and are movable relatively along an axial direction. The inner rod is configured for pushing the expanding part inside a fusion cage. A head end of the anti-torsion sleeve is provided with an external thread section, the external thread section is configured for matching and connecting with the screw plug mounting hole of a holding body of the fusion cage, and the tail end of the anti-torsion sleeve is provided with a matching structure for matching with the bone grafting funnel. A head end of the outer sleeve is matched with the holding body of the fusion cage to restrict the rotation of the fusion cage along an axis of the fusion cage. A surgical instrument assembly is also provided.
    Type: Application
    Filed: March 25, 2020
    Publication date: October 20, 2022
    Inventors: Zhenzhou LI, Guoping FAN, Xiyi HUANG, Yuanzhi XU, Yaling WANG
  • Publication number: 20220300038
    Abstract: A support structure member and a display device. The support structure member includes a first support assembly, including a plurality of support members arranged in a first direction, in which the plurality of support members can be slidably arranged relative to one another in the first direction, and a gap is formed between two adjacent support members, and the first support assembly is bent by each position of the gap; a second support assembly, movably arranged relative to the first support assembly at least one side of the support members in a thickness direction, in which the second support assembly includes a connecting unit and a hinge unit connected to the connecting unit, the second support assembly moves to the gap of the first support assembly, and in the gap, the hinge unit and the support members together support a to-be-supported member.
    Type: Application
    Filed: June 6, 2022
    Publication date: September 22, 2022
    Applicant: Hefei Visionox Technology Co., Ltd.
    Inventors: Yaling Wang, Leichao Zhang, Fang Zhang, Zhengyang Li
  • Patent number: 10865404
    Abstract: The present invention provides an aspartase mutant, a recombinant expression vector and recombinant bacterium containing the aspartase mutant, and the use thereof, and belongs to the technical field of genetic engineering. The amino acid sequence of the aspartase mutant is as set forth in SEQ ID NO: 1. In the aspartase mutant of the present invention, on the basis of wild type aspartase (with an amino acid sequence as set out in SEQ ID NO: 3), glutamic acid at position 427 is mutated into glutamine. In the present invention, by mutating the amino acid residue at position 427 into glutamine, the polar environment near an active site is changed, and thus ammonia supply during substrate reaction is further facilitated, thereby improving an enzyme activity, enhancing the ability of the enzyme in synthesizing a ?-amino acid, and providing a practical and effective strategy for industrial production of the ?-amino acid.
    Type: Grant
    Filed: June 15, 2020
    Date of Patent: December 15, 2020
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Zhiming Rao, Yaling Wang, Jiamin Chen, Taowei Yang, Meijuan Xu, Xian Zhang, Minglong Shao, Jianing Zhang, Anqi Peng, Shuping Xu, Meiqi Wu
  • Publication number: 20200357864
    Abstract: A pixel arrangement structure of display panel and a display apparatus, which are used to solve the technical problem of low pixel aperture ratio of an organic light emitting diode display panel. Herein, a pixel arrangement structure of display panel includes: a plurality of sub-pixels including a first sub-pixel, a second sub-pixel, and a third sub-pixel; where the first sub-pixel, the second sub-pixel, and the third sub-pixel have a polygonal structure with different numbers of sides, and distances between any adjacent two of the plurality of sub-pixels are equal.
    Type: Application
    Filed: July 29, 2020
    Publication date: November 12, 2020
    Applicant: YUNGU (GU'AN) TECHNOLOGY CO., LTD.
    Inventors: Zhihui XIAO, Junjie HUANG, Ping SONG, Weijian SHAN, Yaling WANG, Zhiye YANG
  • Patent number: 10526611
    Abstract: The present invention provides methods and compositions for enhancing the efficiency of Agrobacterium-mediated transformation of host cells, such as plant cells, wherein the host cells overexpress light-dependent short hypocotyls 10 (LSH10) protein. The methods of the invention comprise Agrobacterium-mediated transfer of T-DNA to a plant cell, wherein the T-DNA contains a DNA of interest to be inserted into a plant genome at a homologous position.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: January 7, 2020
    Assignee: Purdue Research Foundation
    Inventors: Stanton B Gelvin, Lan-Ying Lee, Yaling Wang
  • Publication number: 20190076265
    Abstract: The invention discloses a one lumbar zero-profile fusion system, including a holder, opener and nailing machine. The fusion system contains a fuser body, front support block, rear support block and adjustable lever; the fuser body covers the upper fuser body I as well as lower fuser body II, matching with the upper fuser body I; both ends of the fuser body connect to the front support block and rear support block, both of which connect to an adjustable lever; the adjustable lever goes through the said fuser body; rear support block and fuser body are connected with a fixed plate; the left and right side of the fixed plate are equipped with oblong holes which are connected to the fuser body by screw axle; and, the holder is equipped with long circular projection matching with the said oblong hole.
    Type: Application
    Filed: October 13, 2016
    Publication date: March 14, 2019
    Inventors: Lubomír Subert, Yaling WANG, Guoping FAN, Xiyi HUANG, Guangpeng CAI, Wanyu QIU
  • Patent number: 10022156
    Abstract: A minimally invasive screw with double threaded plugs is provided, for connecting to a connecting rod. The screw includes an inner threaded plug, an outer threaded plug, a lengthened arm connector, a press block and a pin with a hollow ball head. The connecting rod can be fixed to the lengthened arm connector via the press block, the inner and outer threaded plugs, to prevent the vertebral body from rotating and loss of intervertebral height when the vertebral body is distracted and pressurized.
    Type: Grant
    Filed: September 3, 2016
    Date of Patent: July 17, 2018
    Assignees: Beijing Fule Science & Technology Development Co., Ltd.
    Inventors: Wenzhi Zhang, Xiyi Huang, Guoshuai Miu, Yaling Wang, Wensheng Lu, Hongyan Li
  • Publication number: 20170290607
    Abstract: A minimally invasive screw with double threaded plugs is provided, for connecting to a connecting rod. The screw includes an inner threaded plug, an outer threaded plug, a lengthened arm connector, a press block and a pin with a hollow ball head. The connecting rod can be fixed to the lengthened arm connector via the press block, the inner and outer threaded plugs, to prevent the vertebral body from rotating and loss of intervertebral height when the vertebral body is distracted and pressurized.
    Type: Application
    Filed: September 3, 2016
    Publication date: October 12, 2017
    Inventors: Wenzhi Zhang, Xiyi Huang, Guoshuai Miu, Yaling Wang, Wensheng Lu, Hongyan Li
  • Publication number: 20170022511
    Abstract: The present invention provides methods and compositions for enhancing the efficiency of Agrobacterium-mediated transformation of host cells, such as plant cells, wherein the host cells overexpress LSH10 protein. The methods of the invention comprise Agrobacterium-mediated transfer of T-DNA to a plant cell, wherein the T-DNA contains a DNA of interest to be inserted into a plant genome at a homologous position.
    Type: Application
    Filed: April 3, 2015
    Publication date: January 26, 2017
    Inventors: Stanton B Gelvin, Lan-Ying Lee, Yaling Wang
  • Patent number: 8637449
    Abstract: The present invention relates to synthetic processes useful in the preparation of macrocyclic compounds of Formula (I) that are useful as inhibitors of the hepatitis C virus NS3 protease and have application in the treatment of conditions caused by the hepatitis C virus. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: January 28, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Zhiguo Jake Song, Yaling Wang, David M. Tellers, Laura M. Artino, David R. Lieberman
  • Patent number: 8507504
    Abstract: The present invention relates to a process for producing a hydrate of 3-(2,6-dichlorophenyl)-4-imino-7-[(2?-methyl-2?,3?-dihydro-1?H-spiro[cyclopropane-1,4?-isoquinolin]-7?-yl)amino]-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one (Compound A) or of a pharmaceutically acceptable salt of Compound A and a crystalline form of Compound A or of a pharmaceutically acceptable salt of Compound A, which are useful in the field of treatment of various cancers as a kinase inhibitor, especially as a Weel kinase inhibitor.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: August 13, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Shuntaro Furukawa, Taketo Ikeno, Shinji Kato, Masashi Kawasaki, Hisaki Kojima, Wataru Minagawa, Naotaka Sawada, Fuyuki Yamamoto, Sachin Lohani, Yaling Wang
  • Publication number: 20120232247
    Abstract: The present invention relates to synthetic processes useful in the preparation of macrocyclic compounds of Formula (I) that are useful as inhibitors of the hepatitis C virus NS3 protease and have application in the treatment of conditions caused by the hepatitis C virus. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.
    Type: Application
    Filed: August 26, 2010
    Publication date: September 13, 2012
    Inventors: Zhiguo Jake Song, Yaling Wang, David M. Tellers, Laura M. Artino, David R. Lieberman
  • Publication number: 20110092520
    Abstract: The present invention relates to a process for producing a hydrate of 3-(2,6-dichlorophenyl)-4-imino-7-[(2?-methyl-2?,3?-dihydro-1?H-spiro[cyclopropane-1,4?-isoquinolin]-7?-yl)amino]-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one (Compound A) or of a pharmaceutically acceptable salt of Compound A and a crystalline form of Compound A or of a pharmaceutically acceptable salt of Compound A, which are useful in the field of treatment of various cancers as a kinase inhibitor, especially as a Weel kinase inhibitor.
    Type: Application
    Filed: June 2, 2009
    Publication date: April 21, 2011
    Inventors: Shuntaro Furukawa, Taketo Ikeno, Shinji Kato, Masashi Kawasaki, Hisaki Kojima, Wataru Minagawa, Naotaka Sawada, Fuyuki Yamamoto, Sachin Lohani, Yaling Wang
  • Patent number: 7893081
    Abstract: This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET, that are useful in the treatment of cellular proliferative diseases, for example cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. In particular, the invention relates to the sodium salt of N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: February 22, 2011
    Assignee: Merck & Co., Inc.
    Inventors: Paolo Avalle, Jennifer R. Foley, Peter Mullens, Yaling Wang, Peter Yehl
  • Patent number: 7700611
    Abstract: The present invention relates to a process for producing crystalline trans-N-[1-(2-fluorophenyl)-S-pyrazoly]-3-ox-ospiro[6-azaisobenzofuran-1(3H),1?-cyclohexane]-4?-carboxamide and novel salts, hydrates and polymorphs thereof.
    Type: Grant
    Filed: July 24, 2006
    Date of Patent: April 20, 2010
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Russell R. Ferlita, Yuji Haga, Makoto Ishikawa, Keisuke Kamei, Shinji Kato, Hisaki Kojima, Aaron Moment, Nobuaki Nonoyama, Nobuya Satake, Kazuki Shigemori, Toshihiro Wada, Yaling Wang, Steven A. Weissman, Robert M. Wenslow
  • Publication number: 20100041893
    Abstract: The present invention is directed to a practical process for the preparation of an enamide (II) by palladium catalyzed coupling of a primary amide (IV) with a compound of structural formula (III), as shown below: As well as to crystalline forms of a compound produced by this process, in particular, an anhydrous crystal form, Form B, and crystalline solvates falling into three patterns, Type 1, Type 2, and Type 3, and crystalline intermediate compounds produced in the process. Still further, the present invention relates to the stereoselective reduction of the tetrasubstituted enamide (II) to the corresponding amide (I).
    Type: Application
    Filed: October 22, 2009
    Publication date: February 18, 2010
    Inventors: KEVIN R. CAMPOS, Artis Klapars, J. Christopher McWilliams, C. Scott Shultz, Debra J. Wallace, Alex M. Chen, Lisa F. Frey, Andrey V. Peresypkin, Yaling Wang, Robert M. Wenslow, Cheng-Yi Chen
  • Patent number: 7629470
    Abstract: The present invention is directed to a practical process for the preparation of an enamide (II) by palladium catalyzed coupling of a primary amide (IV) with a compound of structural formula (III), as shown below: As well as to crystalline forms of a compound produced by this process, in particular, an anhydrous crystal form, Form B, and crystalline solvates falling into three patterns, Type 1, Type 2, and Type 3, and crystalline intermediate compounds produced in the process. Still further, the present invention relates to the stereoselective reduction of the tetrasubstituted enamide (II) to the corresponding amide (I).
    Type: Grant
    Filed: July 1, 2005
    Date of Patent: December 8, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Kevin R. Campos, Artis Klapars, J. Christopher McWilliams, C. Scott Shultz, Debra J. Wallace, Alex M. Chen, Lisa F. Frey, Andrey V. Peresypkin, Yaling Wang, Robert M. Wenslow, Cheng-Yi Chen
  • Publication number: 20090182002
    Abstract: This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET, that are useful in the treatment of cellular proliferative diseases, for example cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. in particular, the invention relates to the sodium salt of N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide.
    Type: Application
    Filed: December 17, 2008
    Publication date: July 16, 2009
    Inventors: Paolo Avalle, Jennifer R. Foley, Peter Mullens, Yaling Wang, Peter Yehl